Press Releases

Perrigo's press releases will keep you updated on the latest news, product launches, foundation gifts and events across the organization.  

September 16, 2019

Perrigo Charitable Foundation Donates More Than $20,000 to Hurricane Dorian Relief Efforts

The Perrigo Charitable Foundation and Perrigo employees have joined together to help victims of Hurricane Dorian both within the U.S. and internationally. Hurricane Dorian impacted multiple southeast states, the Caribbean, and the Bahamas as it made landfall last week.

September 05, 2019

Perrigo Advances Consumer Self-Care Growth Strategy with Acquisition of Prevacid®24HR

Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a definitive agreement to acquire the branded OTC rights to Prevacid® from GlaxoSmithKline.

July 15, 2019

Perrigo Donates $50,000 to the Saugatuck Center for the Arts to Support an Entire Year of Arts Education Programming

DUBLIN, Ireland and Allegan, Michigan – July 15, 2019 --The Perrigo Company Charitable Foundation is proud to announce a donation of $50,000 to the Saugatuck Center for the Arts (SCA) which will support an entire year of arts education programming throughout the tri-county areas of Allegan, Kent, and Ottawa Counties. 

July 08, 2019

Perrigo Completes Divestiture of Animal Health Business

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has completed the previously announced divestiture of its Animal Health business to PetIQ (NASDAQ: PETQ) for $185 million.

July 03, 2019

Perrigo Announces FDA Final Approval and Launch of the AB-Rated Generic Version of Metrogel-Vaginal® Gel

Perrigo Company plc (NYSE; TASE: PRGO) today announced its product development partner received final approval from the U.S. Food and Drug Administration for its AB-rated Abbreviated New Drug Application (“ANDA”) referencing Metrogel-Vaginal® (metronidazole vaginal gel 0.75%).  Perrigo will acquire full ownership of the ANDA under a pre-existing arrangement with its partner within 30 days and anticipates launching this product immediately thereafter. 

July 02, 2019

Perrigo Completes Acquisition Of Ranir, Raises Guidance

Perrigo Company plc (NYSE; TASE: PRGO) today announced the successful completion of its acquisition of Ranir Global Holdings LLC ("Ranir"), the leading global store brand supplier of oral self-care products, for $750 million in cash. This transaction advances Perrigo's transformation to a consumer-focused, self-care company while enhancing its position as a global leader in consumer self-care solutions.

July 01, 2019

Perrigo Charitable Foundation Donates $40,000 to Meals on Wheels Western Michigan

Families in Allegan County who need home delivered meals will now have additional access thanks to the Perrigo Charitable Foundation’s $40,000 gift to West Michigan’s Meals on Wheels Program.

May 21, 2019

Perrigo Announces FDA Final Approval for AB Rated Generic Version of Voltaren® Gel 1%

Dublin, Ireland – May 21, 2019 – Perrigo Company plc (NYSE; TASE: PRGO) today announced its partner received final approval from the U.S.

May 10, 2019

Perrigo Unveils Self-Care Transformation Plan, 2019 Guidance And Long-Term Growth Targets at Investor Day

Dublin, Ireland – May 9, 2019 – Perrigo Company plc (NYSE; TASE: PRGO) today is holding its Investor Day at the New York Stock Exchange in New York City, outlining its strategy to drive long-term g

May 09, 2019

Perrigo to Expand into Adjacent Self-Care Category by Acquiring Ranir Global Holdings LLC, the Leading Global Private Label Supplier of Oral Self-Care Products

  • All cash transaction valued at $750 million, or approximately $685 million inclusive of cash tax benefits on a present value basis
  • Ranir generated net sales of $287 million in calend

Press Inquiries

If you are a member of the press on deadline, please reach out to a member of our Global Investor Relations & Corporate Communications team.